
The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6
Keywords: CLL, chronic lymphocytic leukemia; BMSCs, bone marrow stromal cells; IL-6, interleukin-6; IL-1β, interleukin-1β; bFGF, basic fibroblast growth factor; SDF-1, stromal cell-derived factor-1; STAT3, signal transducer and activator of transcription 3; HDACs,